Pacific Edge Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pacific Edge Limited with three other
miscellaneous service companies in Australasia:
Lbt Innovations Limited
sales of 7.73 million Australian Dollars [US$5.94 million]
(5.17 million Australian Dollars [US$3.98 million]
of which 100%
was Biotechnology), and
Clinuvel Pharmaceuticals Limited
based in Australia
(7.03 million Australian Dollars [US$5.41 million]
of which 100%
Pacific Edge Limited reported sales of 7.14 million New Zealand Dollars (US$5.03 million)
March of 2016.
increase of 85.2%
versus 2015, when the company's sales were 3.86 million New Zealand Dollars.
Sales at Pacific Edge Limited have increased during each of the previous five years
(and since 2011, sales have increased a total of 3,442%).
Sales of Nz Laboratory saw an increase
that was more than double the company's growth rate: sales were up
185.9% in 2016, from
120,321.00 New Zealand Dollars to 344,001.00 New Zealand Dollars.
Pacific Edge Limited also saw significant increases in sales in
Us Laboratory (up 160.6% to 4.63 million New Zealand Dollars)
Not all segments of Pacific Edge Limited experienced an increase in sales in 2016:
sales of Research fell 78.0% to 495.00 New Zealand Dollars.
(However, this segment's sales were only a very small portion of the company's overall sales).